The study was not opened.
Inclusion Criteria:
Patients who have previously been diagnosed with COVID-19 but are now asymptomatic >14 days
and a matched number of healthy controls:
1. Consent: Subject able to provide voluntary written consent before performance of any
study-related procedure not part of normal medical care, with the understanding that
consent may be withdrawn by the subject at any time without prejudice to future
medical care.
2. SARS-CoV-2 Testing Status:
1. Experimental Population: Subject has had positive SARS-CoV-2 verified by clinical
laboratory OR
2. Control Population: Subject without testing or negative SARS-CoV-2 testing
3. Complete resolution and current absence of clinical symptoms Symptoms Defined as:
Fever, Dry cough, Fatigue, Difficulty breathing, Sore throat, Diarrhea, Rhinorrhea
(runny nose), or new aches/pains.
4. Age: Greater or equal to 18 years of age. a. Subject must be able to provide voluntary
written consent
Exclusion Criteria:
1. Ongoing symptoms of COVID19 due to SARS-CoV-2 infection
a. Symptoms Defined as: Fever, Dry cough, Fatigue, Difficulty breathing, Sore throat,
Diarrhea, Rhinorrhea (runny nose), or new aches/pains.
2. Ongoing symptoms not due or not known to be due to SARS-CoV-2 infection
a. Symptoms Defined as: Fever, Dry cough, Fatigue, Difficulty breathing, Sore throat,
Diarrhea, Rhinorrhea (runny nose), or new aches/pains.
3. Patients receiving ongoing medical symptomatic treatment or prophylaxis treatment
related to COVID-19 due to SARS-CoV-2